{"id":399690,"date":"2026-10-26T11:30:22","date_gmt":"2026-10-26T06:00:22","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=399690"},"modified":"2026-10-26T13:45:14","modified_gmt":"2026-10-26T08:15:14","slug":"shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/","title":{"rendered":"Shardul Amarchand Mangaldas &#038; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer"},"content":{"rendered":"<div style=\"text-align: justify; line-height: 150%;\">\n<p style=\"margin-bottom: 3%;\">Shardul Amarchand Mangaldas &amp; Co (SAM) advised Morgan Stanley PE on the sale of 2,500,000 equity shares (representing approximately 2.46% of the paid-up share capital) of Sahajanand Medical Technologies Limited (&#8220;Issuer&#8221;) which comprised (a) sale of 1,335,178 Equity Shares (approx. 1.31%, &#8377;45.93 crore) through an offer for sale in the initial public offering of the Issuer aggregating to &#8377;475.48 crore (approx. US$55.23 million) (&#8220;Offer&#8221;), and (b) secondary transfer of 1,164,822 Equity Shares (approx. 1.15%, &#8377;40.06 crore) prior to the Offer. The equity shares of the Issuer listed on BSE and NSE on October 23, 2026.<\/p>\n<p style=\"margin-bottom: 3%;\">The book running lead managers for the Offer were Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited.<\/p>\n<p style=\"margin-bottom: 3%;\">Sahajanand Medical Technologies is one of the few listed medical devices companies and has a presence across 65 countries.<\/p>\n<p style=\"margin-bottom: 3%;\">The SAM team comprised Nikhil Naredi (Partner), Chinmay Sethia (Principal Associate) and Shariba Tasneem (Associate) on capital markets, and Nivedita Tiwari (Partner), Kuhuk Jain (Principal Associate) and Jasmine Khan (Senior Associate) on general corporate advisory.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p style=\"font-style: italic;\">The book running lead managers for the Offer were Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited and Nuvama Wealth Management Limited.<\/p>\n","protected":false},"author":67011,"featured_media":399691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45282,2],"tags":[116240,112781,62549,88886,118016,118018,59709,118017],"class_list":["post-399690","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-capital-markets-advisory","tag-ipo-transaction","tag-morgan-stanley-private-equity","tag-private-equity-exit","tag-sahajanand-medical-technologies","tag-secondary-share-transfer","tag-shardul-amarchand-mangaldas-co","tag-stake-sale-through-ipo"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.1 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>SAM Advises Morgan Stanley PE | SCC Times<\/title>\n<meta name=\"description\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas &amp; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer\" \/>\n<meta property=\"og:description\" content=\"Shardul Amarchand Mangaldas &amp; Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T06:00:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-26T08:15:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas &amp; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Shardul Amarchand Mangaldas &#038; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer\",\"datePublished\":\"2026-10-26T06:00:22+00:00\",\"dateModified\":\"2026-10-26T08:15:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/\"},\"wordCount\":189,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Sahajanand-Medical-Technologies-stake-sale.webp\",\"keywords\":[\"capital markets advisory\",\"IPO transaction\",\"Morgan Stanley Private Equity\",\"private equity exit\",\"Sahajanand Medical Technologies\",\"secondary share transfer\",\"Shardul Amarchand Mangaldas &amp; Co\",\"stake sale through IPO\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/\",\"name\":\"SAM Advises Morgan Stanley PE | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Sahajanand-Medical-Technologies-stake-sale.webp\",\"datePublished\":\"2026-10-26T06:00:22+00:00\",\"dateModified\":\"2026-10-26T08:15:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"Shardul Amarchand Mangaldas & Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Sahajanand-Medical-Technologies-stake-sale.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Sahajanand-Medical-Technologies-stake-sale.webp\",\"width\":886,\"height\":590,\"caption\":\"Sahajanand Medical Technologies stake sale\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2026\\\/10\\\/26\\\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas &#038; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAM Advises Morgan Stanley PE | SCC Times","description":"Shardul Amarchand Mangaldas & Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas & Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer","og_description":"Shardul Amarchand Mangaldas & Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2026-10-26T06:00:22+00:00","article_modified_time":"2026-10-26T08:15:14+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas & Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Shardul Amarchand Mangaldas &#038; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer","datePublished":"2026-10-26T06:00:22+00:00","dateModified":"2026-10-26T08:15:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/"},"wordCount":189,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.webp","keywords":["capital markets advisory","IPO transaction","Morgan Stanley Private Equity","private equity exit","Sahajanand Medical Technologies","secondary share transfer","Shardul Amarchand Mangaldas &amp; Co","stake sale through IPO"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/","url":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/","name":"SAM Advises Morgan Stanley PE | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.webp","datePublished":"2026-10-26T06:00:22+00:00","dateModified":"2026-10-26T08:15:14+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"Shardul Amarchand Mangaldas & Co. advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through an IPO and secondary transfer.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.webp","width":886,"height":590,"caption":"Sahajanand Medical Technologies stake sale"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2026\/10\/26\/shardul-amarchand-mangaldas-morgan-stanley-pe-sahajanand-medical-technologies-ipo-stake-sale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas &#038; Co advises Morgan Stanley PE on its stake sale in Sahajanand Medical Technologies through IPO and secondary transfer"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_sharing_enabled":true,"jetpack-related-posts":[],"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/10\/Sahajanand-Medical-Technologies-stake-sale.webp","_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/399690","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=399690"}],"version-history":[{"count":4,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/399690\/revisions"}],"predecessor-version":[{"id":399716,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/399690\/revisions\/399716"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/399691"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=399690"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=399690"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=399690"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}